tiprankstipranks
Trending News
More News >
Compass Pathways’ Earnings Call Highlights Progress and Challenges
PremiumCompany AnnouncementsCompass Pathways’ Earnings Call Highlights Progress and Challenges
1M ago
Positive Outlook for COMPASS Pathways: Strong Clinical Progress and Financial Stability Support Buy Rating
Premium
Ratings
Positive Outlook for COMPASS Pathways: Strong Clinical Progress and Financial Stability Support Buy Rating
1M ago
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
Premium
The Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
1M ago
COMPASS Pathways Amends Executive Employment Agreements
PremiumCompany AnnouncementsCOMPASS Pathways Amends Executive Employment Agreements
2M ago
Psychedelic: Exclusive talk with retreat provider ONE Retreats
Premium
The Fly
Psychedelic: Exclusive talk with retreat provider ONE Retreats
3M ago
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
3M ago
COMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry with COMP360 Advancements
PremiumRatingsCOMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry with COMP360 Advancements
3M ago
Optimistic Buy Rating for COMPASS Pathways: Strategic Trials and Strong Financial Position Bolster Confidence in COMP360’s Potential
Premium
Ratings
Optimistic Buy Rating for COMPASS Pathways: Strategic Trials and Strong Financial Position Bolster Confidence in COMP360’s Potential
3M ago
Buy Rating for COMPASS Pathways: Promising Phase 3 Trial Progress and Strong Financial Position
Premium
Ratings
Buy Rating for COMPASS Pathways: Promising Phase 3 Trial Progress and Strong Financial Position
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100